Sheryl Kunning

912 total citations · 3 hit papers
10 papers, 503 citations indexed

About

Sheryl Kunning is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Sheryl Kunning has authored 10 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 1 paper in Surgery. Recurrent topics in Sheryl Kunning's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (3 papers). Sheryl Kunning is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (3 papers). Sheryl Kunning collaborates with scholars based in United States, Germany and France. Sheryl Kunning's co-authors include Tullia C. Bruno, Dario A.A. Vignali, Anthony R. Cillo, Ayana T. Ruffin, Robert L. Ferris, Caleb Lampenfeld, Huda I. Atiya, Lan Coffman, Creg J. Workman and Seungwon Kim and has published in prestigious journals such as Cell, Nature Communications and The Journal of Immunology.

In The Last Decade

Sheryl Kunning

9 papers receiving 499 citations

Hit Papers

B cell signatures and tertiary lymphoid structures contri... 2021 2026 2022 2024 2021 2024 2024 50 100 150 200

Peers

Sheryl Kunning
Lillian Sun United States
Ayana T. Ruffin United States
Michael S. Leibowitz United States
Sarah Greene United States
Maria Anderson United States
Hyun-Bae Jie United States
David A. Clump United States
M.T. Spiotto United States
Houssein Abdul Sater United States
Lillian Sun United States
Sheryl Kunning
Citations per year, relative to Sheryl Kunning Sheryl Kunning (= 1×) peers Lillian Sun

Countries citing papers authored by Sheryl Kunning

Since Specialization
Citations

This map shows the geographic impact of Sheryl Kunning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryl Kunning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryl Kunning more than expected).

Fields of papers citing papers by Sheryl Kunning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheryl Kunning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryl Kunning. The network helps show where Sheryl Kunning may publish in the future.

Co-authorship network of co-authors of Sheryl Kunning

This figure shows the co-authorship network connecting the top 25 collaborators of Sheryl Kunning. A scholar is included among the top collaborators of Sheryl Kunning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheryl Kunning. Sheryl Kunning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ruffin, Ayana T., Sheryl Kunning, Anjali Rohatgi, et al.. (2025). Dysfunctional CD11c CD21 extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Science Translational Medicine. 17(786). eadh1315–eadh1315. 4 indexed citations
2.
Bailey, Nathanael G., Sheryl Kunning, Cynthia S. Hinck, et al.. (2025). TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma. Cancer Research Communications. 5(8). 1441–1457.
3.
Kunning, Sheryl, Huda I. Atiya, Ayana T. Ruffin, et al.. (2024). The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 42(11). 1864–1881.e5. 24 indexed citations
4.
Cillo, Anthony R., Carly Cardello, Feng Shan, et al.. (2024). Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. 187(16). 4373–4388.e15. 75 indexed citations breakdown →
5.
Andrews, Lawrence P., Jian Cui, Anthony R. Cillo, et al.. (2024). LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity. Cell. 187(16). 4355–4372.e22. 110 indexed citations breakdown →
6.
Shan, Feng, Anthony R. Cillo, Carly Cardello, et al.. (2023). Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Science Immunology. 8(87). eadf6717–eadf6717. 16 indexed citations
7.
Somasundaram, Ashwin, Anthony R. Cillo, Caleb Lampenfeld, et al.. (2022). Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells. Cancer Immunology Research. 10(7). 885–899. 18 indexed citations
8.
Ferris, Robert L., Jessica Moskovitz, Sheryl Kunning, et al.. (2022). Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer. Clinical Cancer Research. 28(7). 1335–1344. 25 indexed citations
9.
Ruffin, Ayana T., Anthony R. Cillo, Tracy Tabib, et al.. (2021). B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nature Communications. 12(1). 3349–3349. 230 indexed citations breakdown →
10.
Bruno, Tullia C., Ayana T. Ruffin, Anthony R. Cillo, et al.. (2019). Tumor infiltrating B cells co-localize with CD4 T effector cells within organized tertiary lymphoid structures to present antigen and educate the anti-tumor immune response in human primary tumors. The Journal of Immunology. 202(1_Supplement). 138.15–138.15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026